All News

Pharmaceutical Representative

A coalition of Internet pharmacies, federal and state officials, consumer advocacy groups and medical groups met last November to evaluate online pharmacy practices. The group devised an action plan for consumer education, legislation and regulation to protect patients who shop for prescriptions online.

Pharmaceutical Representative

New York-based Pfizer Inc. filed a lawsuit against Warner-Lambert and American Home Products Corp., both based in Philadelphia, on Nov. 23, 1999, alleging that Warner-Lambert breached its contractual obligations to Pfizer outlined in a standstill agreement between Pfizer and Warner-Lambert. The complaint also alleges that American Home Products wrongfully interfered with Pfizer's contractual arrangement with Warner-Lambert by inducing Warner-Lambert's breach.

Pharmaceutical Representative

Scientists at Philadelphia-based SmithKline Beecham have identified an enzyme that may help drugs target and treat Alzheimer's disease.

Pharmaceutical Representative

In a move that could signal a trend in managed care, UnitedHealthcare, a subsidiary of Minneapolis-based UnitedHealth Group, announced that it is doing away with doctor preauthorization for many inpatient hospital procedures.

Pharmaceutical Representative

Mischele Hoffman is humble. With a background that includes 12 years in sales, two years administering a nonprofit organization for people with disabilities and a master's degree in health sciences, not to mention a highly successful year with Eisai Pharmaceuticals, it would be easy for her not to be. But Hoffman's patient-focused approach to selling and the match she's found in a company that also places a high value on patient advocacy has proved to be a good combination.

FDA: User fee monies drop

Pharmaceutical Representative

Prescription drug user fee revenues will be $59 million lower than originally expected over the five years of the Prescription Drug User Fee Act II, the Food and Drug Administration announced.

Pharmaceutical Representative

Novartis became the fifth pharmaceutical company to join the Academic Medicine and Managed Care Forum.

Reform issue heats up

Pharmaceutical Representative

Reps. John Shadegg (R-AZ) and Tom Coburn (R-OK) added their Health Care Quality and Choice Act to the growing list of managed care bills being considered by Congress.

Pfizer meets LTC needs

Pharmaceutical Representative

Long-term care executives named Pfizer Inc., New York, the pharmaceutical company that best meets their needs.

Pharmaceutical Representative

The potential for medication mix-ups worries patients most, followed by fear of negative drug interactions and treatment costs.

Pharmaceutical Representative

Rep. Sherrod Brown (D-OH) introduced a bill that would use market competition to reduce the cost of prescription drugs.

Pharmaceutical Representative

Drug benefits for enrollees in Medicare health maintenance organizations vary greatly from plan to plan.

Pharmaceutical Representative

The Food and Drug Administration claims that Glaxo Wellcome's Spanish-language television advertisements for Flonase® (fluticasone) nasal spray, which ran in Puerto Rico in 1998 and 1999, failed to disclose risk information.

Pharmaceutical Representative

For-profit hospitals cost the Medicare program more than not-for-profit hospitals, according to a recent article published in the New England Journal of Medicine (vol. 341, no. 6).

Pharmaceutical Representative

The American Heart Association has estimated that patient non-compliance with physician instructions regarding medication use costs the United States $100 billion annually in unnecessary medical costs and lost national productivity.

Pharmaceutical Representative

Johnson & Johnson, New Brunswick, NJ, has entered into an agreement with Centocor Inc., Malvern, PA, under which the two companies will merge.

Pharmaceutical Representative

Congress is considering a bill that would establish an independent review process to consider patent extensions for drugs that spent more time than normal in the FDA review process.

New board members

Pharmaceutical Representative

Pharmaceutical Representative welcomed two new members to its editorial advisory board in 1999: Mark Osborne, director of sales training at Chicago-based Searle and Professor Mickey Smith, professor of pharmacy administration and the director of the Center for Pharmaceutical Marketing and Management at the University of Mississippi.

Pharmaceutical Representative

On July 28, a district court judge in Washington ruled that some provisions of the FDA Modernization Act are unconstitutional because they violate pharmaceutical companies' rights to free speech.

Formulary is evidence-based

Pharmaceutical Representative

An "evidence-based formulary" that compares the safety, efficacy and cost of pharmaceuticals in the top eight therapeutic classes is being made available to clients of Express Scripts.